Application
GALNT9 Antibody (Center) western blot analysis in HL-60 cell line lysates (35ug/lane).This demonstrates the GALNT9 antibody detected the GALNT9 protein (arrow).| Product Name | GALNT9 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | GALNT9 Polypeptide N-acetylgalactosaminyltransferase 9 Polypeptide GalNAc transferase 9 Protein-UDP acetylgalactosaminyltransferase 9 UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9 |
|---|---|
| Molecular Weight(MW) | 68359 Da |
| Function | Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D- galactosamine residue to a serine or threonine residue on the protein receptor. Does not glycosylate apomucin or SDC3 |
| Tissue Specificity | Specifically expressed in brain. Not expressed in heart, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis, ovary, small intestine, colon and leukocyte. In brain, it is expressed in cerebellum, frontal lobe, temporal lobe, putamen and spinal cord, weakly expressed in cerebral cortex. Not expressed in medulla and occipital pole |
| Cellular Localization | Golgi apparatus membrane; Single-pass type II membrane protein (By similarity) |
| Entrez Gene | 50614 |
|---|---|
| Nucleotide Accession | NP_001116108.1 |
Application
GALNT9 Antibody (Center) western blot analysis in HL-60 cell line lysates (35ug/lane).This demonstrates the GALNT9 antibody detected the GALNT9 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
